123 related articles for article (PubMed ID: 6683530)
1. Antimycotic efficacy of bifonazole in vitro and in vivo.
Plempel M; Regel E; Büchel KH
Arzneimittelforschung; 1983; 33(4):517-24. PubMed ID: 6683530
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo studies with flutrimazole, a new imidazole derivative with antifungal activity.
García Rafanell J; Dronda MA; Merlos M; Forn J; Torres JM; Zapatero MI; Basi N
Arzneimittelforschung; 1992 Jun; 42(6):836-40. PubMed ID: 1418042
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.
Yamaguchi H; Hiratani T; Plempel M
Arzneimittelforschung; 1983; 33(4):546-51. PubMed ID: 6683531
[TBL] [Abstract][Full Text] [Related]
4. A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro.
Shadomy S; Dixon DM; May R
Sabouraudia; 1982 Dec; 20(4):313-23. PubMed ID: 7157107
[TBL] [Abstract][Full Text] [Related]
5. In vivo activity of bifonazole in guinea pigs: its characteristic features and comparison with clotrimazole.
Yamaguchi H; Uchida K
Dermatologica; 1984; 169 Suppl 1():33-45. PubMed ID: 6526090
[TBL] [Abstract][Full Text] [Related]
6. Bifonazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.
Lackner TE; Clissold SP
Drugs; 1989 Aug; 38(2):204-25. PubMed ID: 2670516
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the antifungal effect of bifonazole on Torulopsis glabrata and Candida albicans under various in vitro test conditions.
Barug D; Bastiaanse HB
Arzneimittelforschung; 1983; 33(4):524-8. PubMed ID: 6409128
[TBL] [Abstract][Full Text] [Related]
8. [Preclinical and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 1. Susceptibility to bifonazole of clinical isolates of dermatophytes].
Yamaguchi H; Uchida K; Watanabe S; Takahashi H; Nakamura Y; Nakamura E; Nishiyama Y; Teduka M; Tomizawa T; Shimozuma M; Osada A; Kawano S; Nakauchi Y; Wakukawa M; Goto A; Ueda Y; Matsukawa A; Kubo M; Minami H; Arikawa J; Soma Y; Chi HI; Tamaki K
Jpn J Antibiot; 1996 Dec; 49(12):1085-94. PubMed ID: 9032595
[TBL] [Abstract][Full Text] [Related]
9. Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole.
Berg D; Regel E; Harenberg HE; Plempel M
Arzneimittelforschung; 1984; 34(2):139-46. PubMed ID: 6372801
[TBL] [Abstract][Full Text] [Related]
10. Oxiconazole, a new imidazole derivative. Evaluation of antifungal activity in vitro and in vivo.
Polak A
Arzneimittelforschung; 1982; 32(1):17-24. PubMed ID: 7037014
[TBL] [Abstract][Full Text] [Related]
11. Experimental in vitro and in vivo comparison of modern antimycotics.
Haller I; Plempel M
Curr Med Res Opin; 1977-1978; 5(4):315-27. PubMed ID: 630908
[TBL] [Abstract][Full Text] [Related]
12. Bifonazole, a biochemist's view.
Berg D; Plempel M
Dermatologica; 1984; 169 Suppl 1():3-9. PubMed ID: 6396116
[TBL] [Abstract][Full Text] [Related]
13. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
Jegasothy BV; Pakes GE
Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718
[TBL] [Abstract][Full Text] [Related]
14. Six novel antimycotics.
Rubin AI; Bagheri B; Scher RK
Am J Clin Dermatol; 2002; 3(2):71-81. PubMed ID: 11893219
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapeutic evaluation of clotrimazole (Bay b 5097, 1 (o-chloro- - -diphenylbenzyl) imidazole).
Waitz JA; Moss EL; Weinstein MJ
Appl Microbiol; 1971 Nov; 22(5):891-8. PubMed ID: 4943591
[TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.
Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs.
Niwano Y; Seo A; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H
Antimicrob Agents Chemother; 1994 Sep; 38(9):2204-6. PubMed ID: 7811048
[TBL] [Abstract][Full Text] [Related]
18. Microscopic studies of Candida albicans and Torulopsis glabrata after in vitro treatment with bifonazole. Light and scanning electron microscopy.
Barug D; Samson RA; Kerkenaar A
Arzneimittelforschung; 1983; 33(4):528-37. PubMed ID: 6347209
[TBL] [Abstract][Full Text] [Related]
19. [In vitro antifungal activity of omoconazole nitrate, a new imidazole antimycotic].
Itoyama T; Aoki Y; Hiratani T; Uchida K; Yamaguchi H
Jpn J Antibiot; 1993 Sep; 46(9):773-80. PubMed ID: 8254897
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of fungicidal action in vitro and in a skin model considering the influence of penetration kinetics of various standard antimycotics.
Hänel H; Raether W; Dittmar W
Ann N Y Acad Sci; 1988; 544():329-37. PubMed ID: 3214073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
